Galectin Therapeutics Files 8-K on Financials
Ticker: GALT · Form: 8-K · Filed: May 15, 2025 · CIK: 1133416
| Field | Detail |
|---|---|
| Company | Galectin Therapeutics INC (GALT) |
| Form Type | 8-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k, company-update
Related Tickers: GALT
TL;DR
GALECTIN THERAPEUTICS (GALT) FILED AN 8-K ON MAY 15, 2025, DETAILING FINANCIALS AND OPERATIONS.
AI Summary
Galectin Therapeutics Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition, as well as filing financial statements and exhibits. The company, formerly known as PRO Pharmaceuticals Inc., is incorporated in Nevada and headquartered in Norcross, Georgia.
Why It Matters
This filing provides crucial updates on Galectin Therapeutics' financial health and operational status, which are important for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- GALECTIN THERAPEUTICS INC. (company) — Registrant
- PRO PHARMACEUTICALS INC (company) — Former company name
- May 15, 2025 (date) — Date of report
- Norcross, GA (location) — Company headquarters
- Nevada (location) — State of incorporation
FAQ
What is the primary purpose of this Form 8-K filing for Galectin Therapeutics Inc.?
The primary purpose of this Form 8-K filing is to report on the company's Results of Operations and Financial Condition, and to file Financial Statements and Exhibits.
When was the report filed and what is the date of the earliest event reported?
The report was filed on May 15, 2025, and the date of the earliest event reported is also May 15, 2025.
What was Galectin Therapeutics Inc. formerly known as?
Galectin Therapeutics Inc. was formerly known as PRO PHARMACEUTICALS INC.
In which state is Galectin Therapeutics Inc. incorporated?
Galectin Therapeutics Inc. is incorporated in Nevada.
What is the principal executive office address for Galectin Therapeutics Inc.?
The principal executive office address is 4960 PEACHTREE INDUSTRIAL BOULEVARD, STE 240, NORCROSS, GA 30071.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding GALECTIN THERAPEUTICS INC (GALT).